Deucravacitinib
Preliminary reference disclaimer
This preliminary safety reference is generated from structured MolGraph catalog fields and public reference-style data. It is not a supplier-issued Safety Data Sheet and should not be used as a substitute for supplier-issued documentation, workplace safety review, transport classification, or regulatory compliance decisions. For supplier SDS or COA, submit a documentation request through MolGraph.
Preliminary safety reference
Available
Supplier-issued SDS
Available by request
COA
Available by RFQ / lot confirmation
Transport classification
Requires shipment review
CAS Number
1609392-27-9
Chemical name
Deucravacitinib
Molecular formula
C20H22N8O3
Molecular weight
425.5 g/mol
Synonyms
Sotyktu; Tyk2-IN-4; Deucravacitinib [USAN]; 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide; Deucravacitinib (BMS-986165); 6-[(Cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-N-(methyl-d3)-3-pyridazinecarboxamide; Tyk2-IN-4(BMS986165); bms 986165; Sotyktu (TN); Deucravacitinib (JAN/USAN); DEUCRAVACITINIB [INN]; DEUCRAVACITINIB [JAN]
InChIKey
BZZKEPGENYLQSC-FIBGUPNXSA-N
PubChem CID
134821691
Signal word
Warning
Catalog reference cue; confirm supplier documentation before use.
Hazard statements
H302, H315, H319
Catalog reference cue; confirm supplier documentation before use.
XLogP
1.2
Catalog reference value; verify against supplier SDS before use.
Shipment review
Shipment details require review before fulfillment.
Transport classification must be confirmed using supplier SDS and shipment documentation before dispatch.